𝔖 Bobbio Scriptorium

✦ LIBER ✦

Double refractile crystals(DRC) in the lung tissue of lung cancer patients exposed to asbestos

Book ID: 123173929
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 87 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80167-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased Apolipoprotein E Gene Expressi

Increased Apolipoprotein E Gene Expression and Protein Concentration in Lung Cancer Tissue Do Not Contribute to the Clinical Assessment of Non-small Cell Lung Cancer Patients

✍ Zoran Trost; Janja Marc; Miha Sok; Darko Cerne 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Determination of the serum matrix metall

Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment

✍ Cynthia Jumper; Everardo Cobos; Charles Lox 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 159 KB

P-285 Tissue microarray (TMA) of mediast

P-285 Tissue microarray (TMA) of mediastinoscopy specimens to assess the p53 pathway in stage IIIA non-small cell lung cancer: Impact on outcome in patients treated with pre-operative chemotherapy

✍ Patel, Jyoti D.; Sarkaria, Inderpal S.; Miller, Vincent A.; Ghossein, Ronald; Ve 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB

A multicentre, randomised, double-blind,

A multicentre, randomised, double-blind, placebo controlled, parallel group study to investigate the efficacy and tolerability of leucomax® (molgramostim; rHu GM-CSF) in conjunction with combination chemotherapy in the treatment of intermediate / poor prognosis patients with small cell lung cancer (SCLC)

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

9017 POSTER DISCUSSION Initial Detection

9017 POSTER DISCUSSION Initial Detection of the Double Epidermal Growth Factor Receptor (EGFR) Mutation (L858R or Deletion in Exon 19 [del 19] Plus T790M) in Non-Small-Cell Lung Cancer (NSCLC) Patients (p) With Brain Metastases (mets) and the Influence of First-Line Chemotherapy on Outcome to Erlotinib

✍ Rolfo, C.; Moran, T.; Sanchez, J.; Molina-Vila, M.; Bertran-Alamilllo, J.; Camps 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB